Publication Information

{'id': 'https://openalex.org/W1646596313', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-07', 'title': 'Abstract OT1-1-07: A phase III study of abemaciclib (LY2835219) combined with fulvestrant in women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (MONARCH 2)', 'display_name': 'Abstract OT1-1-07: A phase III study of abemaciclib (LY2835219) combined with fulvestrant in women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer (MONARCH 2)', 'publication_year': 2015, 'publication_date': '2015-05-01', 'ids': {'openalex': 'https://openalex.org/W1646596313', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-07', 'mag': '1646596313'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-07', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030451537', 'display_name': 'Antonio Llombart‐Cussac', 'orcid': 'https://orcid.org/0000-0003-4515-8293'}, 'institutions': [{'id': 'https://openalex.org/I4210119293', 'display_name': 'Hospital Arnau de Vilanova', 'ror': 'https://ror.org/02s7fkk92', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119293']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Antonio Llombart', 'raw_affiliation_strings': ['1Hospital Arnau de Vilanova'], 'affiliations': [{'raw_affiliation_string': '1Hospital Arnau de Vilanova', 'institution_ids': ['https://openalex.org/I4210119293']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091245889', 'display_name': 'Masakazu Toi', 'orcid': 'https://orcid.org/0000-0003-1488-9958'}, 'institutions': [{'id': 'https://openalex.org/I22299242', 'display_name': 'Kyoto University', 'ror': 'https://ror.org/02kpeqv85', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I22299242']}, {'id': 'https://openalex.org/I57790213', 'display_name': 'Matsumoto University', 'ror': 'https://ror.org/02rttk866', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I57790213']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masakazu Toi', 'raw_affiliation_strings': ['2Kyoto University', 'Kyoto univ.'], 'affiliations': [{'raw_affiliation_string': 'Kyoto univ.', 'institution_ids': ['https://openalex.org/I22299242']}, {'raw_affiliation_string': '2Kyoto University', 'institution_ids': ['https://openalex.org/I57790213']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034411688', 'display_name': 'Suzanne Klise', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I168537998', 'display_name': 'Eli Lilly (United States)', 'ror': 'https://ror.org/01qat3289', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I168537998']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Suzanne R Klise', 'raw_affiliation_strings': ['#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#'], 'affiliations': [{'raw_affiliation_string': '#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#', 'institution_ids': ['https://openalex.org/I168537998']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040919295', 'display_name': 'Martin Frenzel', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I168537998', 'display_name': 'Eli Lilly (United States)', 'ror': 'https://ror.org/01qat3289', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I168537998']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Martin Frenzel', 'raw_affiliation_strings': ['#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#'], 'affiliations': [{'raw_affiliation_string': '#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#', 'institution_ids': ['https://openalex.org/I168537998']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083329029', 'display_name': 'Edward M. Chan', 'orcid': 'https://orcid.org/0000-0002-1332-2987'}, 'institutions': [{'id': 'https://openalex.org/I168537998', 'display_name': 'Eli Lilly (United States)', 'ror': 'https://ror.org/01qat3289', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I168537998']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Edward M Chan', 'raw_affiliation_strings': ['#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#'], 'affiliations': [{'raw_affiliation_string': '#N##TAB##TAB##TAB##TAB# Eli Lilly and Company#N##TAB##TAB##TAB#', 'institution_ids': ['https://openalex.org/I168537998']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5066769011', 'display_name': 'George W. Sledge', 'orcid': 'https://orcid.org/0000-0003-0297-0775'}, 'institutions': [{'id': 'https://openalex.org/I2800038579', 'display_name': 'Stratford University', 'ror': 'https://ror.org/00zbnzw74', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I2800038579']}, {'id': 'https://openalex.org/I97018004', 'display_name': 'Stanford University', 'ror': 'https://ror.org/00f54p054', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I97018004']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'George W Sledge', 'raw_affiliation_strings': ['4Stanford University'], 'affiliations': [{'raw_affiliation_string': '4Stanford University', 'institution_ids': ['https://openalex.org/I2800038579', 'https://openalex.org/I97018004']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 6, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.697, 'has_fulltext': False, 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.679106, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 84, 'max': 85}, 'biblio': {'volume': '75', 'issue': '9_Supplement', 'first_page': 'OT1', 'last_page': '07'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9224, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/fulvestrant', 'display_name': 'Fulvestrant', 'score': 0.9545475}, {'id': 'https://openalex.org/keywords/palbociclib', 'display_name': 'Palbociclib', 'score': 0.46407273}], 'concepts': [{'id': 'https://openalex.org/C2780482068', 'wikidata': 'https://www.wikidata.org/wiki/Q5508491', 'display_name': 'Fulvestrant', 'level': 5, 'score': 0.9545475}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8319582}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.7649472}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.62021244}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.5892119}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5621812}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.5105961}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.48783663}, {'id': 'https://openalex.org/C2779744173', 'wikidata': 'https://www.wikidata.org/wiki/Q15269707', 'display_name': 'Palbociclib', 'level': 5, 'score': 0.46407273}, {'id': 'https://openalex.org/C84606932', 'wikidata': 'https://www.wikidata.org/wiki/Q416496', 'display_name': 'Estrogen receptor', 'level': 4, 'score': 0.27623233}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.088354975}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs14-ot1-1-07', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.86, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4283528480', 'https://openalex.org/W4232409591', 'https://openalex.org/W4206711305', 'https://openalex.org/W3216407617', 'https://openalex.org/W3161515104', 'https://openalex.org/W2982700532', 'https://openalex.org/W2897446380', 'https://openalex.org/W2892043300', 'https://openalex.org/W2605489431', 'https://openalex.org/W2588818478'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Abemaciclib': [2, 61, 201], '(LY2835219),': [3], 'an': [4, 64, 297, 370, 415], 'oral': [5], 'drug': [6], 'administered': [7, 229], 'twice': [8], 'daily': [9], 'on': [10, 79, 173, 208, 231, 240], 'a': [11, 15, 35, 46, 70, 87, 124, 214, 382, 395], 'continuous': [12], 'schedule,': [13], 'is': [14, 123, 316, 430], 'cell': [16], 'cycle': [17], 'inhibitor': [18], 'of': [19, 30, 38, 48, 131, 176, 213, 236, 243, 306, 313, 359, 374, 385, 421, 464, 492], 'both': [20, 68], 'CDK4': [21], 'and': [22, 45, 73, 186, 223, 234, 246, 296, 357, 407, 425], 'CDK6.': [23], 'In': [24], 'Study': [25], 'I3Y-MC-JPBA,': [26], 'abemaciclib': [27, 82, 136, 324, 465], 'demonstrated': [28, 63], 'evidence': [29], 'single': [31, 71], 'agent': [32, 72], 'activity': [33], 'in': [34, 56, 74, 93, 372, 388, 399, 470], 'tumor-specific': [36], 'cohort': [37], 'patients': [39], 'with': [40, 58, 76, 95, 99, 133, 139, 170, 253, 333, 468, 472], 'metastatic': [41, 103, 152, 260, 339], 'breast': [42, 116, 153, 261, 340, 485], 'cancer': [43, 262, 486], '(MBC)': [44], 'median': [47, 383, 401], '7': [49], 'prior': [50, 192, 268, 275], 'therapies;': [51], 'all': [52], 'responses': [53], 'observed': [54], 'were': [55], 'women': [57, 98, 138, 252, 332, 471], 'HR+': [59], 'disease.': [60], 'also': [62], 'acceptable': [65], 'safety': [66], 'profile': [67], 'as': [69], 'combination': [75, 94], 'fulvestrant.': [77], 'Based': [78], 'these': [80], 'results,': [81], 'has': [83, 365], 'been': [84], 'entered': [85], 'into': [86], 'Phase': [88, 128], 'III': [89, 129, 462], 'study': [90, 130, 364, 463], '(MONARCH': [91, 487], '2)': [92, 488], 'fulvestrant': [96, 132, 224, 326, 330, 469], 'for': [97, 137, 331], 'locally': [100, 142, 257, 336], 'advanced': [101, 143, 258, 337], 'or': [102, 134, 151, 217, 259, 271, 288, 338], 'hormone': [104, 473], 'receptor': [105, 112, 474, 481], 'positive': [106, 475], '(HR+),': [107, 476], 'human': [108, 477], 'epidermal': [109, 478], 'growth': [110, 479], 'factor': [111, 480], '2': [113, 121, 245, 315, 482], 'negative': [114, 483], '(HER2-)': [115, 484], 'cancer.': [117, 154, 341], 'Trial': [118], 'design:': [119], 'MONARCH': [120, 314], '(NCT02107703)': [122], 'randomized,': [125], 'double-blind,': [126], 'placebo-controlled': [127], 'without': [135], 'HR+,': [140, 254, 334], 'HER2-': [141, 255, 335], '(not': [144], 'amenable': [145], 'to': [146, 188, 211, 283, 317, 345, 368, 394, 403, 413], 'curative': [147], 'treatment': [148, 322], 'by': [149], 'surgery)': [150], 'Patients': [155, 280], 'will': [156, 219, 227, 409], 'be': [157, 220, 228, 410], 'randomized': [158], '2:1': [159], '(Arm': [160], 'A': [161, 460], '[abemaciclib': [162], 'plus': [163, 168, 325, 329], 'fulvestrant]:': [164], 'Arm': [165], 'B': [166], '[placebo': [167], 'fulvestrant]': [169], 'stratification': [171], 'based': [172], 'the': [174, 389, 400, 493], 'nature': [175], 'disease': [177, 287], '(visceral': [178], 'metastases': [179, 183], 'versus': [180, 184, 195, 198, 327], 'bone': [181, 290], 'only': [182, 291], 'other)': [185], 'sensitivity': [187], 'endocrine': [189, 193, 269, 276], 'therapy': [190, 194, 270, 277], '(no': [191], 'primary': [196, 311], 'resistance': [197], 'secondary': [199], 'resistance).': [200], '(200': [202], 'mg': [203, 226], 'every': [204], '12': [205], 'hours': [206], '[Q12H]': [207], 'Days': [209, 232], '1': [210, 233, 242], '28': [212], '28-day': [215], 'cycle)': [216], 'placebo': [218, 328], 'given': [221], 'orally': [222], '500': [225], 'intramuscularly': [230], '15': [235], 'Cycle': [237, 244], '1,': [238], 'then': [239], 'Day': [241], 'subsequent': [247], 'cycles.': [248], 'Eligibility': [249], 'criteria:': [250], 'Postmenopausal': [251], 'inoperable': [256], 'who': [263], 'have': [264, 272, 284], 'either': [265, 285], 'relapsed': [266], 'after': [267], 'not': [273], 'received': [274], 'are': [278, 281, 344], 'eligible.': [279], 'required': [282], 'measurable': [286], 'non-measurable': [289], 'disease,': [292], 'adequate': [293], 'organ': [294], 'function': [295], 'Eastern': [298], 'Cooperative': [299], 'Oncology': [300], 'Group': [301], '(ECOG)': [302], 'performance': [303], 'status': [304], '(PS)': [305], '≤1.': [307], 'Specific': [308], 'aims:': [309], 'The': [310, 363], 'objective': [312, 349], 'compare': [318, 346], 'PFS': [319, 373, 384, 402, 406], 'between': [320], 'two': [321], 'arms:': [323], 'Secondary': [342], 'objectives': [343], 'overall': [347, 416], 'survival,': [348], 'response': [350], 'rate,': [351, 354], 'clinical': [352], 'benefit': [353], 'safety,': [355], 'pharmacokinetics': [356], 'quality': [358], 'life.': [360], 'Statistical': [361], 'methods:': [362], '90%': [366], 'power': [367], 'detect': [369], 'increase': [371, 398], 'approximately': [375, 431], '42%': [376], '(hazard': [377], 'ratio': [378], '=': [379], '.703).': [380], 'Assuming': [381], '6.5': [386], 'mos.': [387, 405], 'control': [390], 'arm,': [391], 'this': [392], 'corresponds': [393], '2.75': [396], 'month': [397], '9.25': [404], 'OS': [408], 'hierarchically': [411], 'tested': [412], 'maintain': [414], 'type': [417], 'I': [418], 'error': [419], 'rate': [420], '2.5%.': [422], 'Present': [423], 'accrual': [424, 429], 'target': [426], 'accrual:': [427], 'Target': [428], '550': [432], 'patients.': [433], 'Contact': [434], 'information:': [435], 'For': [436], 'further': [437], 'information': [438], 'please': [439], 'contact': [440], '1-877-CTLILLY': [441], '(1-877-285-4559).': [442], 'Citation': [443], 'Format:': [444], 'Antonio': [445, 498], 'Llombart,': [446], 'Masakazu': [447], 'Toi,': [448], 'Suzanne': [449], 'R': [450], 'Klise,': [451], 'Martin': [452], 'Frenzel,': [453], 'Edward': [454], 'M': [455], 'Chan,': [456], 'George': [457], 'W': [458], 'Sledge.': [459], 'phase': [461], '(LY2835219)': [466], 'combined': [467], '[abstract].': [489], 'In:': [490], 'Proceedings': [491], 'Thirty-Seventh': [494], 'Annual': [495], 'CTRC-AACR': [496], 'San': [497, 505], 'Breast': [499], 'Cancer': [500, 511], 'Symposium:': [501], '2014': [502], 'Dec': [503], '9-13;': [504], 'Antonio,': [506], 'TX.': [507], 'Philadelphia': [508], '(PA):': [509], 'AACR;': [510], 'Res': [512], '2015;75(9': [513], 'Suppl):Abstract': [514], 'nr': [515], 'OT1-1-07.': [516]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1646596313', 'counts_by_year': [{'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}], 'updated_date': '2025-01-13T02:55:12.451711', 'created_date': '2016-06-24'}